A carregar...
Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
Globally, chronic hepatitis B (CHB) infection is one of the leading causes of liver failure, decompensated cirrhosis, and hepatocellular carcinoma. Existing antiviral therapy can suppress viral replication but not fully eradicate the virus nor the risk of liver-related complications. Novel treatment...
Na minha lista:
| Publicado no: | Viruses |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235765/ https://ncbi.nlm.nih.gov/pubmed/34207458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13061169 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|